Med Page Today
OCTOBER 11, 2024
(MedPage Today) -- Loneliness increased the risk for all-cause dementia, a meta-analysis that included more than 600,000 people showed. Feeling lonely was tied to a 31% higher risk of overall dementia (HR 1.306, 95% CI 1.197-1.426), according.
HCPLive
OCTOBER 11, 2024
New phase 2b data highlight denifanstat’s impact on histological features of MASH, meeting both fibrosis improvement and MASH resolution primary endpoints.
Med Page Today
OCTOBER 11, 2024
(MedPage Today) -- For a range of hospitalized patients at risk of worsening heart failure (HF), tying medical interventions to cardiac monitoring seemed safe thus far according to the small ALLEVIATE-HF trial. There were no serious adverse events.
HCPLive
OCTOBER 11, 2024
A study finds CGRP monoclonal antibodies are not clinically superior to topiramate or Botox in treating chronic migraines, raising cost-effectiveness concerns.
American College of Cardiology
OCTOBER 11, 2024
The goal of the EAST-AFNET 4 trial was to compare a rhythm-control strategy vs. usual care (rate control in the majority of cases) among patients with a recent diagnosis of atrial fibrillation (AF).
HCPLive
OCTOBER 11, 2024
Factors, including older age at onset and longer length of stay, may predict longevity for schizophrenia in psychiatric long-term care settings.
American College of Cardiology
OCTOBER 11, 2024
In this episode of CardiaCast, hypertrophic cardiomyopathy (HCM) expert Dr. Matthew Martinez will discuss with Dr. Michelle Kittleson recommendations for early diagnosis in the 2024 HCM guideline and review the latest clinical and real-world trial data for new (mavacamten) and emerging (aficamten) cardiac myosin inhibitors.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
NEJM Journal Watch - Cardiology
OCTOBER 11, 2024
New recommendations in these updated American College of Cardiology/American Heart Association guidelines include selective measurement of cardiac biomarkers.
HCPLive
OCTOBER 11, 2024
The anti-TFPI significantly reduced ABR compared to routine prophylaxis treatment in the phase 3 BASIS trial.
Becker's Hospital Review - Cardiology
OCTOBER 11, 2024
Banner-University Medical Center Phoenix has become the third U.S. hospital to perform a BiVACOR Total Artificial Heart implantation as part of the FDA's early feasibility study.
HCPLive
OCTOBER 11, 2024
A meta-analysis revealed taking pregabalin with supplement vitamin D reduced migraine frequency in children by 88%
Cardiovascular Diabetology
OCTOBER 11, 2024
Diabetic macroangiopathy has been the main cause of death and disability in diabetic patients. The mechanisms underlying smooth muscle cell transformation and metabolic reprogramming other than abnormal glucos.
HCPLive
OCTOBER 11, 2024
Linda Gillam, MD, MPH, discusses the idea that the cardiology community may. be overtreating aortic stenosis.
Journal of Cardiothoracic Surgery
OCTOBER 11, 2024
Pectus excavatum is the most common chest wall deformity, with the Nuss procedure being the preferred surgical approach for correction. However, the decision to use thoracoscopic assistance remains challenging.
HCPLive
OCTOBER 11, 2024
Calabrese discussed considerations for patients with rheumatic disease diagnosed with COVID-19 and the virus’s role in promoting inflammation.
Dr. Paddy Barrett
OCTOBER 11, 2024
Obesity is one of the world’s biggest health crisis and only seems to be getting worse. Or is it? Maybe we have turned the tide on one of the most pressing health issues of the century. For over 50 years, the rates of obesity have continued to rise worldwide 1. That is until now. The most recent data on obesity has shown a decline for the first time in a very long time.
HCPLive
OCTOBER 11, 2024
This research letter suggests that direct GOC may be considered efficacious for pediatric patients reporting non-severe symptoms which are skin-limited during a macrolide treatment.
Dr. S. Venkatesan MD
OCTOBER 11, 2024
Cardiac resynchronisation (CRT )as a modality for severe or refractory cardiac failure is practiced for nearly two decades. It works on the principle of aggregating mechanically wasted and disorganized myocardial contractile force into a coherent forward pushing activity. In the process, improving the ejection fraction and possibly reducing mitral regurgitation.
AMS Cardiology
OCTOBER 11, 2024
Heart disease remains a leading cause of death worldwide despite advancements in medical science and healthcare. Unfortunately, many misconceptions surround this condition, leading to delayed diagnosis, inappropriate treatment and preventable health risks. Below, we aim to debunk common myths about cardiovascular disease, providing accurate information and emphasizing the importance of treatment for heart disease with timely interventions.
Med Page Today
OCTOBER 11, 2024
(MedPage Today) -- FDA advisors indicated a possible path forward for elamipretide as a treatment for Barth syndrome despite the lack of definitive evidence. On Thursday, the Cardiovascular and Renal Drugs Advisory Committee voted 10-6 that elamipretide.
HCPLive
OCTOBER 11, 2024
Findings support the feasibility and clinical performance of Xpert HCV, the first FDA-approved point-of-care test for diagnosing HCV, in a nonclinical justice setting.
American College of Cardiology
OCTOBER 11, 2024
The goal of the APPRAISE ATP trial was to determine the efficacy of antitachycardia pacing (ATP) in terminating ventricular tachycardia (VT) compared with a shock-only strategy in patients with a primary prevention implantable cardioverter-defibrillator (ICD).
HCPLive
OCTOBER 11, 2024
The sNDA submission to the FDA included a Priority Review Voucher, which commits the regulatory agency to an accelerated review timeline.
American College of Cardiology
OCTOBER 11, 2024
What is the prevalence and impact of recurrent rejection (RR) on cardiac allograft vasculopathy (CAV) and graft loss after pediatric heart transplant?
HCPLive
OCTOBER 11, 2024
A new AHA statement highlights the benefits of lipoprotein apheresis for familial hypercholesterolemia and urges broader access to the underutilized therapy.
American College of Cardiology
OCTOBER 11, 2024
What are Class I Food and Drug Administration (FDA) recalls of cardiovascular devices and what is the clinical evidence supporting authorization?
Journal of the American Heart Association
OCTOBER 11, 2024
Journal of the American Heart Association, Ahead of Print. BackgroundCerebral microbleeds (CMBs) are common and varied in patients receiving extracorporeal membrane oxygenation (ECMO). Here, the authors describe CMB findings in patients receiving ECMO and their association with clinical factors.Methods and ResultsA total of 138 patients receiving ECMO were enrolled and categorized as venovenous and venoarterial.
The American Journal of Cardiology
OCTOBER 11, 2024
Publication date: Available online 11 October 2024 Source: The American Journal of Cardiology Author(s): Allison Kratka, Gregory Rohrbach, Carrie Puckett, Thomas L. Rotering, Merritt H. Raitt, Mary A. Whooley, Sanket S.
Journal of the American Heart Association
OCTOBER 11, 2024
Journal of the American Heart Association, Ahead of Print.
The American Journal of Cardiology
OCTOBER 11, 2024
Publication date: Available online 11 October 2024 Source: The American Journal of Cardiology Author(s): Carlos Diaz-Arocutipa, Norma Nicole Gamarra-Valverde, Rafael Salguero, Roberto Martín-Asenjo, Lourdes Vicent
Journal of the American Heart Association
OCTOBER 11, 2024
Journal of the American Heart Association, Ahead of Print.
Physiologically Speaking
OCTOBER 11, 2024
Greetings! Welcome to the Physiology Friday newsletter. Details about the sponsors of this newsletter including FSTFUEL electrolytes, Examine.com , and my book “VO2 Max Essentials ” can be found at the end of the post! Physiologically Speaking is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Journal of the American Heart Association
OCTOBER 11, 2024
Journal of the American Heart Association, Ahead of Print. BackgroundAlternative splicing in the eighth exon C‐terminus of VEGF‐A (vascular endothelial growth factor‐A) results in the formation of proangiogenic VEGF165a and antiangiogenic VEGF165b isoforms. The only known difference between these 2 isoform families is a 6‐amino acid switch from CDKPRR (in VEGF165a) to SLTRKD (in VEGF165b).
Expert insights. Personalized for you.
116 
Let's personalize your content